Polaris Genomics is a brand at the forefront of precision genomic solutions for post-traumatic stress disorder (PTSD). By combining genomics and artificial intelligence (AI), they bring clarity and objectivity to the assessment, diagnosis, and treatment of neuropsychiatric conditions. Their personalized, precision mental health care approach is designed for everyone.

Through their diverse and comprehensive multi-omic data repository, Polaris Genomics develops tools that offer clinical and research advantages for mental health. Their upstream solutions and unprecedented products, including the PTS-ID™ Genomic Test, TruGen-1™ Assay, TruNorth™ Platform, and Endeavor Lab™, provide objective genomic insights, reveal gene expression and flux, and revolutionize mental health research. By leveraging genomics to link mental health with its underlying biology, Polaris Genomics aims to shorten the diagnostic journey and enable timely and targeted intervention.

They are dedicated to making invisible wounds like PTSD visible and transforming mental health care. Connect with Polaris Genomics to learn more about their tools and current research, and subscribe to their newsletter for the latest updates in genomic-led mental health care